CIK: 0001232621
Total reported value
$2.0B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HRTX | Heron Therapeutics INC | Stock-Other | 49.08% | -0.15% | +5.51% | |
| 2 | LJPC | La Jolla Pharmaceutical Co | Stock-Other | 19.82% | — | +24.28% | |
| 3 | ✓ | Bio-reference Labs INC | Stock-Other | 11.26% | — | — | |
| 4 | OPK 3 02-01-33 AI | Opko Health INC | Stock-Other | 10.05% | — | — | |
| 5 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 7.57% | — | — | |
| 6 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | Stock-Other | 2.22% | — | -36.36% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | HRTX | Heron Therapeutics INC | +11% | +5.51% | Add |
| 2 | LJPC | La Jolla Pharmaceutical Co | -1.1% | +24.28% | Add |
| 3 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | -3.7% | -36.36% | Trim |
| 4 | BMRN | Biomarin Pharmaceutical INC | -4.5% | — | Unchanged |
| 5 | OPK 3 02-01-33 AI | Opko Health INC | -5.6% | — | Unchanged |
| 6 | ✓ | Bio-reference Labs INC | — | NEW | New buy |
| 7 | MRTXEUR | Mirati Therapeutics INC | — | EXIT | Sold out |
| 8 | ✓ | Oncogenex Pharmaceuticals In | — | EXIT | Sold out |
| 9 | ✓ | Rxi Pharmaceuticals CORP | — | EXIT | Sold out |